Eli Lilly stock dips despite strong Q2 results. Read my insights on obesity drug market dominance and why this selloff in LLY ...

So far this earnings season, companies in the S&P 500 that miss Wall Street's estimates for earnings per share and sales have ...

This would indicate a 6% year-over-year growth in earnings and a 3% increase in sales when compared to the previous year’s ...

Second-quarter earnings season is in full swing, and the results have been largely resilient so far. So why are stocks ...

Historically, the stock has reacted positively to its earnings reports, with a one-day price increase in 67% of instances ...

Discover key insights from CACI's Q4 2025 earnings call, highlighting robust growth, strategic focus on software-defined tech, and confident fiscal ...

Second-quarter adjusted earnings came in at 78 cents a share on revenue of $14.7 billion, beating expectations.

MFC Q2 results reflect strong business growth in Global WAM, Asia, and Canada, offset by unfavorable life insurance claims experience in the United States.

Pfizer ( PFE) reported a beat in second quarter earnings Tuesday, and reaffirmed its 2025 guidance of between $61 to $64 ...

Q2 2025 Management View Paul Richards, EVP and CFO, reported "For the second quarter, we reported a net income of $0.54 per ...

Earnings per share is one of the best metrics of a company’s financial health. In this guide, Benzinga discusses the ins and outs of earnings per share (EPS).

In Q2, the chipmaker's data center revenue grew just 14% year over year, versus 57% in Q1, due to the export controls that ...